We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Johnson and Johnson | NYSE:JNJ | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.27 | -0.18% | 152.40 | 850 | 11:14:00 |
From May 2021 to May 2024
By Matt Grossman
Johnson & Johnson on Wednesday raised its guidance for adjusted earnings and for revenue growth in 2021.
The New Brunswick, N.J.-based pharmaceutical company said it now expects adjusted earnings of $9.60 to $9.70 a share this year. In April, it had forecast adjusted earnings of $9.42 to $9.57 a share.
The company said it now expects sales of $93.8 billion to $94.6 billion. In April, it had forecast sales of $90.6 billion to $91.6 billion.
The earnings and sales forecasts include estimates of J&J's Covid-19 vaccine operations.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
July 21, 2021 06:58 ET (10:58 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Johnson and Johnson Chart |
1 Month Johnson and Johnson Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
